title: Phase 1b trial of atacicept, a recombinant protein binding BLyS and APRIL, in patients with chronic lymphocytic leukemia.
authors: D M
authors: DM
authors: Kofler
authors: B B
authors: BB
authors: Gawlik
authors: T
authors: T
authors: Elter
authors: A
authors: A
authors: Gianella-Borradori
authors: C-M
authors: CM
authors: Wendtner
authors: M
authors: M
authors: Hallek
mesh_terms: D053264:B-Cell Activating Factor / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D011993:Recombinant Fusion Proteins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13 / Q000235:genetics / Q000378:metabolism*
chemical_list: D053264:B-Cell Activating Factor; D011993:Recombinant Fusion Proteins; C114631:TNFSF13 protein, human; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13; C524618:TACI receptor-IgG Fc fragment fusion protein